The global Closed IV Spikes Market Growth is projected to grow from USD 335 million in 2026 to USD 760 million by 2036, registering a steady 8.5% CAGR. Valued at USD 310 million in 2025, the market is expected to create an absolute opportunity of USD 425 million by 2036.

Get detailed market forecasts: Sample Copy

Market expansion reflects the increasing adoption of closed transfer technologies, rising emphasis on infection prevention, expanding oncology treatment volumes, and growing demand for sterile medication preparation. Healthcare providers worldwide are investing in safer infusion systems that reduce contamination risk, improve medication handling, and support compliance with evolving clinical safety standards.

Key Market Highlights at a Glance

• Market size (2025): USD 310 million
• Market size (2026): USD 335 million
• Forecast size (2036): USD 760 million
• CAGR (2026–2036):5%
• Absolute opportunity: USD 425 million
• Leading spike type: Closed Spikes (35.0% share in 2026)
• Leading safety feature: Needle-Free Systems (33.0% share in 2026)
• Leading fluid type: IV Fluids (39.0% share in 2026)
• Leading end user: Hospitals (58.0% share in 2026)
• Fastest-growing major country: United States (8.9% CAGR)

Key Growth Drivers

Safe infusion practices are strengthening across hospitals, pharmacies, and outpatient facilities globally. Increasing oncology drug preparation is expanding demand for contamination-resistant transfer systems. Furthermore, hospitals are steadily adopting closed transfer devices to reduce medication exposure and leakage risks, supported by infection prevention standards and expanding sterile compounding services.

Unlock insights for strategic planning: Checkout Report

Expert Analyst Perspective

Shambhu Nath Jha, Senior Analyst at Fact.MR, commented: "Closed IV spikes are becoming an important part of safe infusion practice. Healthcare providers continue adopting closed transfer devices that reduce contamination risk and improve medication handling. Growing demand for oncology infusion and sterile compounding will support long-term market growth."

Segmental Analysis

Spike Type: Closed Spikes Lead with 35.0% Share

Closed Spikes are expected to account for 35.0% of the market in 2026, making them the leading segment. Their popularity stems from their ability to minimize fluid exposure, maintain sterile transfer pathways, and reduce leakage during medication preparation and administration.

Safety Feature: Needle-Free Systems Capture 33.0% Share

Needle-Free Systems are projected to represent 33.0% of market demand in 2026. Healthcare providers continue adopting needle-free technologies to reduce occupational exposure risks, improve staff safety, and prevent accidental needlestick injuries.

Fluid Type: IV Fluids Account for 39.0% Revenue

IV Fluids are expected to hold 39.0% market share in 2026. Because IV fluids are administered across virtually every healthcare setting, demand for sterile transfer solutions remains consistently high.

End User: Hospitals Hold 58.0% Share

Hospitals are projected to account for 58.0% of market revenue in 2026. Hospitals perform the majority of infusion procedures, oncology treatments, and sterile compounding activities, driving accelerated adoption of closed transfer technologies.

Gain Access to Market Forecasts: Full Report

Market Dynamics

• Drivers: Expansion of infusion safety initiatives, rising oncology treatment volumes, increased utilization of sterile compounding services, and strengthening infection prevention standards.
• Restraints: Higher product costs compared with conventional IV spikes, budget constraints in smaller healthcare facilities, and procurement-related adoption delays.
• Trends: Expansion of needle-free transfer technologies, growth in oncology-focused infusion safety solutions, and greater use of closed systems in compounding pharmacies.

High-Growth Opportunity Areas

• Oncology Pharmacies: Growing cancer treatment volumes continue increasing demand for safe drug preparation systems.
• Compounding Pharmacies: Sterile compounding growth supports the adoption of contamination-control technologies.
• Home Infusion Services: Expanding home-based infusion therapy programs drive demand for safer medication transfer systems.
• Ambulatory Surgery Centers: Rising outpatient procedure volumes increase demand for workflow-efficient infusion products.

Regional and Country Outlook (CAGR 2026–2036)

• United States (8.9%): Leads global growth due to continuous investment in infusion safety programs and widespread adoption of closed transfer devices.
• Germany (8.6%): Driven by strict medication-handling protocols and healthcare quality initiatives across hospitals and compounding pharmacies.
• Japan (8.4%): Supported by expanding infusion safety programs and modernization of medication handling practices.
• China (8.2%): Fueled by growing hospital infrastructure investments and expanding oncology services.
• South Korea (8.0%): Driven by increased oncology care capacity and broader healthcare investments.

Competitive Landscape

Leading companies in the Closed IV Spikes Market include B. Braun, ICU Medical, Fresenius Kabi, CODAN, Vygon, and JMS Co., Ltd. (developer of NEOSHIELD™ closed system drug transfer technologies). Manufacturers are focusing on next-generation closed transfer technologies that reduce leakage, improve sterile handling, and support compliance with healthcare guidelines.

Discover Healthcare Industry Insights: Fact.MR Healthcare

Top Trending Reports

• Closed-Loop Centesis Systems Market
• Closed-Loop Enteral Feeding Sensors Market
• Closed Blood Sampling Systems Market
• IV Bag and Tubing Recycling Market